Literature DB >> 12670499

Regulation of STAT3 activity by G16-coupled receptors.

Eddy H T Wu1, Rico K H Lo, Yung H Wong.   

Abstract

A number of G protein-coupled receptors (GPCRs) have been shown to stimulate signal transducers and activators of transcription (STAT) activities while STAT3 activation by G alpha(o) can lead to neoplastic transformation in fibroblasts. In the present study we examined the ability of GPCRs to activate STAT3 via G alpha(16), a G alpha subunit which is primarily expressed in hematopoietic cells. In HEK 293 cells expressing a STAT3-driven luciferase reporter, the G alpha(16)-coupled ORL(1) and fMLP receptors stimulated luciferase activity upon activation by their agonists. Agonist-induced STAT3 activity required coexpression of G alpha(16) and was resistant to PTX treatment. Upon activation of the ORL(1) and fMLP receptors, phosphorylation of STAT3 at Tyr(705) was detected by immunoblot analysis. Additional experiments indicated that GPCR-mediated STAT3 activation was dependent on JAK and Raf1 signaling, but did not require phosphatidylinositol 3-kinase. This is the first study that demonstrates the stimulatory effect of ORL(1) and fMLP receptors on STAT3 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670499     DOI: 10.1016/s0006-291x(03)00451-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  α(1A)-adrenergic receptor differentially regulates STAT3 phosphorylation through PKCϵ and PKCδ in myocytes.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2012-01-24       Impact factor: 2.092

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptor.

Authors:  Matthew J Finley; Amber Steele; William D Cornwell; Thomas J Rogers
Journal:  J Leukoc Biol       Date:  2011-03-29       Impact factor: 4.962

4.  Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6.

Authors:  Rodger E Tiedemann; Yuan Xiao Zhu; Jessica Schmidt; Hongwei Yin; Chang-Xin Shi; Qiang Que; Gargi Basu; David Azorsa; Louise M Perkins; Esteban Braggio; Rafael Fonseca; P Leif Bergsagel; Spyro Mousses; A Keith Stewart
Journal:  Blood       Date:  2009-12-07       Impact factor: 22.113

5.  Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system.

Authors:  T A Barnes; J McDonald; D J Rowbotham; T L Duarte; D G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-25       Impact factor: 3.000

Review 6.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

7.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

8.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

9.  Mutations on the Switch III region and the alpha3 helix of Galpha16 differentially affect receptor coupling and regulation of downstream effectors.

Authors:  May Ym Yu; Maurice Kc Ho; Andrew Mf Liu; Yung H Wong
Journal:  J Mol Signal       Date:  2008-11-22

10.  Gβγ-mediated activation of protein kinase D exhibits subunit specificity and requires Gβγ-responsive phospholipase Cβ isoforms.

Authors:  Winnie Wi Lau; Anthony Sl Chan; Lydia Sw Poon; Jing Zhu; Yung H Wong
Journal:  Cell Commun Signal       Date:  2013-04-05       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.